Date:
Combination drug regimens that incorporate anti-CD38 monoclonal antibodies, immunomodulatory drugs, proteasome inhibitors, and glucocorticoids are routinely used for the treatment of newly diagnosed multiple myeloma.1 Consequently, at the first relapse, patients have already been exposed to the most effective available drug classes and potentially have refractory disease, so…
The New England Journal of Medicine: Search Results in Hematology/Oncology
Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.
© 2021 tagDiv. All Rights Reserved. Made with Newspaper Theme.
